Arnoud Boot

researcher

Arnoud Boot is …
instance of (P31):
humanQ5

External links are
P2798Loop ID284985
P496ORCID iD0000-0002-7717-7416
P1153Scopus author ID57189347792

P1889different fromArnoud BootQ2479974
P69educated atLeiden UniversityQ156598
Rotterdam University of Applied SciencesQ2139672
P108employerLeiden UniversityQ156598
Duke–NUS Medical SchoolQ5312721
Erasmus MCQ3126873
GenomeScan (Netherlands)Q104481171
P734family nameBootQ16860234
P106occupationresearcherQ1650915
pathologistQ3368718
P21sex or gendermaleQ6581097

Reverse relations

author (P50)
Q64059376Allelic Switching of , , and during Colorectal Cancer Tumorigenesis
Q47431964Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
Q51140131Associations of polymorphisms of eight muscle- or metabolism-related genes with performance in Mount Olympus marathon runners
Q41056167BRAF mutation-specific promoter methylation of FOX genes in colorectal cancer
Q97527130Characterization of colibactin-associated mutational signature in an Asian oral squamous cell carcinoma and in other mucosal tumor types
Q38792685Characterization of novel low passage primary and metastatic colorectal cancer cell lines
Q38672032Chemosensitivity of BRCA1-Mutated Ovarian Cancer Cells and Established Cytotoxic Agents
Q41532605Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia
Q38652450Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors
Q92303390Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
Q90082719HLA-G protein expression in colorectal cancer evaluated by immunohistochemistry and western blot analysis: Its expression characteristics remain enigmatic
Q48042328Imprinted survival genes preclude loss of heterozygosity of chromosome 7 in cancer cells.
Q52720551In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors
Q41911913Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines
Q100466495Multiple neoplasia in a patient with Gitelman syndrome harboring germline monoallelic MUTYH mutation
Q38767295Promoter methylation and mRNA expression of HLA-G in relation to HLA-G protein expression in colorectal cancer.
Q46275699ROS-induced near-homozygous genomes in thyroid cancer.
Q36265886Recurrent Coding Sequence Variation Explains Only A Small Fraction of the Genetic Architecture of Colorectal Cancer
Q38839775Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
Q35755480Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells.
Q37288532The homeobox gene MEIS1 is methylated in BRAF (p.V600E) mutated colon tumors
Q89557119The repertoire of mutational signatures in human cancer
Q37631429Tumor LINE-1 Methylation Level in Association with Survival of Patients with Stage II Colon Cancer.
Q40151513Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma.

Q2479974Arnoud Bootdifferent fromP1889

Search more.